RUNFOLA, MASSIMILIANO
 Distribuzione geografica
Continente #
EU - Europa 471
NA - Nord America 381
AS - Asia 50
AF - Africa 35
SA - Sud America 4
Totale 941
Nazione #
US - Stati Uniti d'America 379
IT - Italia 222
SE - Svezia 101
AT - Austria 40
BG - Bulgaria 34
FR - Francia 29
CI - Costa d'Avorio 23
SG - Singapore 23
DE - Germania 15
CN - Cina 10
VN - Vietnam 7
HK - Hong Kong 6
PL - Polonia 6
SN - Senegal 6
GB - Regno Unito 5
BR - Brasile 4
BE - Belgio 3
CZ - Repubblica Ceca 3
NL - Olanda 3
UA - Ucraina 3
CA - Canada 2
EG - Egitto 2
FI - Finlandia 2
JP - Giappone 2
MK - Macedonia 2
NG - Nigeria 2
BD - Bangladesh 1
CH - Svizzera 1
GH - Ghana 1
KR - Corea 1
PT - Portogallo 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 941
Città #
Chandler 64
Fairfield 44
Serra 41
Vienna 39
Pisa 38
Sofia 34
Abidjan 23
Ashburn 20
Wilmington 20
Carrara 18
Princeton 17
Woodbridge 17
Marseille 16
Lawrence 14
Seattle 13
Livorno 12
New York 12
Houston 11
Cambridge 10
Medford 10
Frankfurt am Main 9
Middleton 9
Ann Arbor 7
Boardman 7
Dakar 6
Hong Kong 6
Pessac 6
San Diego 6
Warsaw 6
Norwalk 5
Ogden 5
Pescara 5
San Giorgio Jonico 4
San Giuliano Terme 4
Beijing 3
Brussels 3
Florence 3
Gaeta 3
Genoa 3
Grosseto 3
Irpin 3
Los Angeles 3
Oxford 3
Redwood City 3
Rome 3
Siena 3
Singapore 3
Busto Arsizio 2
Cascina 2
Cetraro 2
Des Moines 2
Dong Ket 2
Giza 2
Helsinki 2
Lagos 2
Lucca 2
Massarosa 2
Migliarino Pisano 2
Monsummano Terme 2
Olomouc 2
Paris 2
Skopje 2
Talence 2
Tokyo 2
Washington 2
Bremen 1
Buffalo 1
Chaoyang 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Jena 1
Jinan 1
Kamampa 1
Langhirano 1
Modena 1
Monticello 1
Mountain View 1
Noisy-le-sec 1
Omegna 1
Ottawa 1
Phoenix 1
Pretoria 1
Redmond 1
Sassari 1
Serravalle Pistoiese 1
Teramo 1
Toronto 1
Vicopisano 1
Waltham 1
Waunakee 1
Wuhan 1
Zurich 1
Totale 661
Nome #
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 104
SG‐2: A SYNTHETIC ANALOG OF THYROID HORMONE METABOLITE 3‐IODOTHYRONAMINE (T1AM), PREVENTS β‐AMYLOID NEUROTOXICITY IN VITRO 77
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective 70
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders 66
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS) 66
Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids 66
Beyond antioxidant effects: Nature-based templates unveil new strategies for neurodegenerative diseases 60
NOVEL THYROMIMETICS WITH A BIPHENYLMETHANE SCAFFOLD AND THEIR USE 58
SG-2: A promising lipolytic and pro-autophagic hit-compound to treat Alzheimer’s disease 57
Diphenyl-methane based thyromimetic inhibitors for transthyretin amyloidosis 56
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile 52
Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics 50
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 46
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD 43
Late breaker posters 41
null 34
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer's Disease 15
Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges 10
Totale 971
Categoria #
all - tutte 3.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 2 0 0 10 2 10 6 9 6 5 1 2
2020/2021123 1 2 8 0 0 16 17 12 35 3 9 20
2021/2022240 3 11 3 15 36 28 25 14 18 21 22 44
2022/2023347 43 29 21 18 39 54 6 24 76 7 12 18
2023/2024197 40 14 21 21 11 26 19 3 0 3 22 17
Totale 971